XML 37 R20.htm IDEA: XBRL DOCUMENT v3.24.1
EARNINGS PER SHARE
12 Months Ended
Dec. 31, 2023
EARNINGS PER SHARE  
EARNINGS PER SHARE

14. EARNINGS PER SHARE

The following represents the calculation of earnings (loss) per share (in thousands, except per share amounts):

Years Ended December 31,

    

2023

  

2022

Basic:

Net (loss) income

$

(3,048)

$

18,539

Less: Preferred stock dividend

(12,047)

Less: Undistributed earnings allocable to preferred stockholders

Net (loss) income available to common stockholders

$

(15,095)

$

18,539

Weighted average basic number of common shares outstanding basic

16,441

16,331

Basic net (loss) income per share of common stock

$

(0.92)

$

1.14

Diluted:

Net (loss) income available to common stockholders basic

$

(15,095)

$

18,539

Reallocation of undistributed earnings

Net (loss) income available to common stockholders diluted

$

(15,095)

$

18,539

Weighted average basic number of common shares outstanding

16,441

16,331

Common stock equivalent shares representing shares issuable upon:

Exercise of warrants and stock options

Anti-dilutive

Anti-dilutive

Vesting of restricted stock units

Anti-dilutive

179

Weighted average diluted number of common shares outstanding diluted

16,441

16,510

Diluted net income (loss) per share of common stock

$

(0.92)

$

1.12

For the year ended December 31, 2023, common stock equivalents, including stock options and certain restricted stock units, totaling 0.5 million weighted-average shares were anti-dilutive and not included in the computation of diluted earnings per share of common stock. For the year ended December 31, 2022, common stock equivalents, including warrants, stock options and restricted stock units, totaling 5.8 million shares were not included in the

computation of diluted earnings per share of common stock because the effect would have been anti-dilutive due to the Company’s net loss in the period. Additionally, the Company also has approximately 0.1 million restricted stock units that vest only upon achievement of certain business combination goals or based on the Company’s TSR as further described in Note 12, “Stockholder’s Equity”. On October 8, 2022 approximately 6.9 million warrants expired which previously gave the holder the right to purchase one share of common stock for each warrant.